US4217344A
(en)
|
1976-06-23 |
1980-08-12 |
L'oreal |
Compositions containing aqueous dispersions of lipid spheres
|
US4235871A
(en)
|
1978-02-24 |
1980-11-25 |
Papahadjopoulos Demetrios P |
Method of encapsulating biologically active materials in lipid vesicles
|
US4186183A
(en)
|
1978-03-29 |
1980-01-29 |
The United States Of America As Represented By The Secretary Of The Army |
Liposome carriers in chemotherapy of leishmaniasis
|
US4261975A
(en)
|
1979-09-19 |
1981-04-14 |
Merck & Co., Inc. |
Viral liposome particle
|
US4485054A
(en)
|
1982-10-04 |
1984-11-27 |
Lipoderm Pharmaceuticals Limited |
Method of encapsulating biologically active materials in multilamellar lipid vesicles (MLV)
|
US4501728A
(en)
|
1983-01-06 |
1985-02-26 |
Technology Unlimited, Inc. |
Masking of liposomes from RES recognition
|
US4897355A
(en)
|
1985-01-07 |
1990-01-30 |
Syntex (U.S.A.) Inc. |
N[ω,(ω-1)-dialkyloxy]- and N-[ω,(ω-1)-dialkenyloxy]-alk-1-yl-N,N,N-tetrasubstituted ammonium lipids and uses therefor
|
US5049386A
(en)
|
1985-01-07 |
1991-09-17 |
Syntex (U.S.A.) Inc. |
N-ω,(ω-1)-dialkyloxy)- and N-(ω,(ω-1)-dialkenyloxy)Alk-1-YL-N,N,N-tetrasubstituted ammonium lipids and uses therefor
|
US4946787A
(en)
|
1985-01-07 |
1990-08-07 |
Syntex (U.S.A.) Inc. |
N-(ω,(ω-1)-dialkyloxy)- and N-(ω,(ω-1)-dialkenyloxy)-alk-1-yl-N,N,N-tetrasubstituted ammonium lipids and uses therefor
|
US4797368A
(en)
|
1985-03-15 |
1989-01-10 |
The United States Of America As Represented By The Department Of Health And Human Services |
Adeno-associated virus as eukaryotic expression vector
|
US4774085A
(en)
|
1985-07-09 |
1988-09-27 |
501 Board of Regents, Univ. of Texas |
Pharmaceutical administration systems containing a mixture of immunomodulators
|
US5422251A
(en)
|
1986-11-26 |
1995-06-06 |
Princeton University |
Triple-stranded nucleic acids
|
US4837028A
(en)
|
1986-12-24 |
1989-06-06 |
Liposome Technology, Inc. |
Liposomes with enhanced circulation time
|
US5176996A
(en)
|
1988-12-20 |
1993-01-05 |
Baylor College Of Medicine |
Method for making synthetic oligonucleotides which bind specifically to target sites on duplex DNA molecules, by forming a colinear triplex, the synthetic oligonucleotides and methods of use
|
US5264618A
(en)
|
1990-04-19 |
1993-11-23 |
Vical, Inc. |
Cationic lipids for intracellular delivery of biologically active molecules
|
WO1991017424A1
(en)
|
1990-05-03 |
1991-11-14 |
Vical, Inc. |
Intracellular delivery of biologically active substances by means of self-assembling lipid complexes
|
US5173414A
(en)
|
1990-10-30 |
1992-12-22 |
Applied Immune Sciences, Inc. |
Production of recombinant adeno-associated virus vectors
|
US5420032A
(en)
|
1991-12-23 |
1995-05-30 |
Universitge Laval |
Homing endonuclease which originates from chlamydomonas eugametos and recognizes and cleaves a 15, 17 or 19 degenerate double stranded nucleotide sequence
|
US5356802A
(en)
|
1992-04-03 |
1994-10-18 |
The Johns Hopkins University |
Functional domains in flavobacterium okeanokoites (FokI) restriction endonuclease
|
US5487994A
(en)
|
1992-04-03 |
1996-01-30 |
The Johns Hopkins University |
Insertion and deletion mutants of FokI restriction endonuclease
|
US5436150A
(en)
|
1992-04-03 |
1995-07-25 |
The Johns Hopkins University |
Functional domains in flavobacterium okeanokoities (foki) restriction endonuclease
|
US5792632A
(en)
|
1992-05-05 |
1998-08-11 |
Institut Pasteur |
Nucleotide sequence encoding the enzyme I-SceI and the uses thereof
|
US5587308A
(en)
|
1992-06-02 |
1996-12-24 |
The United States Of America As Represented By The Department Of Health & Human Services |
Modified adeno-associated virus vector capable of expression from a novel promoter
|
CA2681922C
(en)
|
1994-01-18 |
2012-05-15 |
The Scripps Research Institute |
Zinc finger protein derivatives and methods therefor
|
US6242568B1
(en)
|
1994-01-18 |
2001-06-05 |
The Scripps Research Institute |
Zinc finger protein derivatives and methods therefor
|
US6140466A
(en)
|
1994-01-18 |
2000-10-31 |
The Scripps Research Institute |
Zinc finger protein derivatives and methods therefor
|
ES2316148T3
(es)
|
1994-03-23 |
2009-04-01 |
Ohio University |
Acidos nucleicos compactados y su suministro a celulas.
|
US5585245A
(en)
|
1994-04-22 |
1996-12-17 |
California Institute Of Technology |
Ubiquitin-based split protein sensor
|
GB9824544D0
(en)
|
1998-11-09 |
1999-01-06 |
Medical Res Council |
Screening system
|
EP2022856B1
(en)
|
1994-08-20 |
2011-09-14 |
Gendaq Limited |
Improvements in or relating to binding proteins for recognition of DNA
|
US5789538A
(en)
|
1995-02-03 |
1998-08-04 |
Massachusetts Institute Of Technology |
Zinc finger proteins with high affinity new DNA binding specificities
|
US5925523A
(en)
|
1996-08-23 |
1999-07-20 |
President & Fellows Of Harvard College |
Intraction trap assay, reagents and uses thereof
|
US6458574B1
(en)
*
|
1996-09-12 |
2002-10-01 |
Transkaryotic Therapies, Inc. |
Treatment of a α-galactosidase a deficiency
|
GB2338237B
(en)
|
1997-02-18 |
2001-02-28 |
Actinova Ltd |
In vitro peptide or protein expression library
|
GB9703369D0
(en)
|
1997-02-18 |
1997-04-09 |
Lindqvist Bjorn H |
Process
|
US6342345B1
(en)
|
1997-04-02 |
2002-01-29 |
The Board Of Trustees Of The Leland Stanford Junior University |
Detection of molecular interactions by reporter subunit complementation
|
GB9710809D0
(en)
|
1997-05-23 |
1997-07-23 |
Medical Res Council |
Nucleic acid binding proteins
|
GB9710807D0
(en)
|
1997-05-23 |
1997-07-23 |
Medical Res Council |
Nucleic acid binding proteins
|
IL135578A0
(en)
*
|
1997-10-29 |
2001-05-20 |
Genzyme Corp |
Compositions and methods for treating lysosomal storage disease
|
US6410248B1
(en)
|
1998-01-30 |
2002-06-25 |
Massachusetts Institute Of Technology |
General strategy for selecting high-affinity zinc finger proteins for diverse DNA target sites
|
EP1060261B1
(en)
|
1998-03-02 |
2010-05-05 |
Massachusetts Institute of Technology |
Poly zinc finger proteins with improved linkers
|
US6140081A
(en)
|
1998-10-16 |
2000-10-31 |
The Scripps Research Institute |
Zinc finger binding domains for GNN
|
US6453242B1
(en)
|
1999-01-12 |
2002-09-17 |
Sangamo Biosciences, Inc. |
Selection of sites for targeting by zinc finger proteins and methods of designing zinc finger proteins to bind to preselected sites
|
US6599692B1
(en)
|
1999-09-14 |
2003-07-29 |
Sangamo Bioscience, Inc. |
Functional genomics using zinc finger proteins
|
US7013219B2
(en)
|
1999-01-12 |
2006-03-14 |
Sangamo Biosciences, Inc. |
Regulation of endogenous gene expression in cells using zinc finger proteins
|
US7070934B2
(en)
|
1999-01-12 |
2006-07-04 |
Sangamo Biosciences, Inc. |
Ligand-controlled regulation of endogenous gene expression
|
US6534261B1
(en)
|
1999-01-12 |
2003-03-18 |
Sangamo Biosciences, Inc. |
Regulation of endogenous gene expression in cells using zinc finger proteins
|
US6794136B1
(en)
|
2000-11-20 |
2004-09-21 |
Sangamo Biosciences, Inc. |
Iterative optimization in the design of binding proteins
|
US7030215B2
(en)
|
1999-03-24 |
2006-04-18 |
Sangamo Biosciences, Inc. |
Position dependent recognition of GNN nucleotide triplets by zinc fingers
|
WO2001040798A2
(en)
|
1999-12-06 |
2001-06-07 |
Sangamo Biosciences, Inc. |
Methods of using randomized libraries of zinc finger proteins for the identification of gene function
|
WO2001059450A2
(en)
|
2000-02-08 |
2001-08-16 |
Sangamo Biosciences, Inc. |
Cells expressing zinc finger protein for drug discovery
|
US20020061512A1
(en)
|
2000-02-18 |
2002-05-23 |
Kim Jin-Soo |
Zinc finger domains and methods of identifying same
|
WO2001088197A2
(en)
|
2000-05-16 |
2001-11-22 |
Massachusetts Institute Of Technology |
Methods and compositions for interaction trap assays
|
US6852510B2
(en)
|
2000-07-03 |
2005-02-08 |
Gala Design Inc |
Host cells containing multiple integrating vectors
|
MXPA03000765A
(es)
|
2000-07-24 |
2004-05-21 |
Gendel Ltd |
Suministro de polipeptido il-2.
|
JP2002060786A
(ja)
|
2000-08-23 |
2002-02-26 |
Kao Corp |
硬質表面用殺菌防汚剤
|
GB0024550D0
(pt)
|
2000-10-06 |
2000-11-22 |
Oxford Biomedica Ltd |
|
US7419829B2
(en)
|
2000-10-06 |
2008-09-02 |
Oxford Biomedica (Uk) Limited |
Vector system
|
ES2437815T3
(es)
|
2000-10-11 |
2014-01-14 |
Shire Human Genetic Therapies, Inc. |
ARN mensajero optimizado
|
US7067317B2
(en)
|
2000-12-07 |
2006-06-27 |
Sangamo Biosciences, Inc. |
Regulation of angiogenesis with zinc finger proteins
|
GB0108491D0
(en)
|
2001-04-04 |
2001-05-23 |
Gendaq Ltd |
Engineering zinc fingers
|
US7030846B2
(en)
|
2001-07-10 |
2006-04-18 |
Samsung Electronics Co., Ltd. |
Color correction liquid crystal display and method of driving same
|
US20040224385A1
(en)
|
2001-08-20 |
2004-11-11 |
Barbas Carlos F |
Zinc finger binding domains for cnn
|
US7262054B2
(en)
|
2002-01-22 |
2007-08-28 |
Sangamo Biosciences, Inc. |
Zinc finger proteins for DNA binding and gene regulation in plants
|
US8106255B2
(en)
|
2002-01-23 |
2012-01-31 |
Dana Carroll |
Targeted chromosomal mutagenasis using zinc finger nucleases
|
AU2003218382B2
(en)
|
2002-03-21 |
2007-12-13 |
Sangamo Therapeutics, Inc. |
Methods and compositions for using zinc finger endonucleases to enhance homologous recombination
|
US7074596B2
(en)
|
2002-03-25 |
2006-07-11 |
Board Of Supervisors Of Louisiana State University And Agricultural And Mechanical College |
Synthesis and use of anti-reverse mRNA cap analogues
|
US7361635B2
(en)
|
2002-08-29 |
2008-04-22 |
Sangamo Biosciences, Inc. |
Simultaneous modulation of multiple genes
|
AU2003298574B2
(en)
|
2002-09-05 |
2008-04-24 |
California Institute Of Technology |
Use of chimeric nucleases to stimulate gene targeting
|
US7446098B2
(en)
*
|
2003-02-18 |
2008-11-04 |
Mount Sinai School Of Medicine Of New York University |
Combination therapy for treating protein deficiencies
|
US7888121B2
(en)
|
2003-08-08 |
2011-02-15 |
Sangamo Biosciences, Inc. |
Methods and compositions for targeted cleavage and recombination
|
US8409861B2
(en)
|
2003-08-08 |
2013-04-02 |
Sangamo Biosciences, Inc. |
Targeted deletion of cellular DNA sequences
|
US7972854B2
(en)
|
2004-02-05 |
2011-07-05 |
Sangamo Biosciences, Inc. |
Methods and compositions for targeted cleavage and recombination
|
EP1732614B1
(en)
|
2004-04-08 |
2008-12-24 |
Sangamo Biosciences Inc. |
Compositions for treating neuropathic and neurodegenerative conditions
|
CA2562193A1
(en)
|
2004-04-08 |
2005-10-27 |
Sangamo Biosciences, Inc. |
Treatment of neuropathic pain with zinc finger proteins
|
AU2005287278B2
(en)
|
2004-09-16 |
2011-08-04 |
Sangamo Biosciences, Inc. |
Compositions and methods for protein production
|
US8008468B2
(en)
|
2005-02-16 |
2011-08-30 |
Benitec, Inc. |
RNAi expression constructs with liver-specific enhancer/promoter
|
EP1877583A2
(en)
|
2005-05-05 |
2008-01-16 |
Arizona Board of Regents on behalf of the Unversity of Arizona |
Sequence enabled reassembly (seer) - a novel method for visualizing specific dna sequences
|
KR101419729B1
(ko)
|
2005-07-26 |
2014-07-17 |
상가모 바이오사이언스 인코포레이티드 |
외래 핵산 서열의 표적화된 통합 및 발현
|
CA2626262C
(en)
|
2005-10-18 |
2015-09-08 |
Homme W. Hellinga |
Rationally-designed meganucleases with altered sequence specificity and dna-binding affinity
|
WO2007058381A1
(ja)
*
|
2005-11-18 |
2007-05-24 |
Tokyo Metropolitan Organization For Medical Research |
基質特異性を変換した新規高機能酵素
|
EP2765195A1
(en)
|
2006-05-25 |
2014-08-13 |
Sangamo BioSciences, Inc. |
Methods and compositions for gene inactivation
|
CA2651494C
(en)
|
2006-05-25 |
2015-09-29 |
Sangamo Biosciences, Inc. |
Engineered cleavage half-domains
|
WO2008133938A2
(en)
|
2007-04-26 |
2008-11-06 |
Sangamo Biosciences, Inc. |
Targeted integration into the ppp1r12c locus
|
EP3252161B1
(en)
|
2007-06-06 |
2021-11-17 |
Genzyme Corporation |
Gene therapy for lysosomal storage diseases
|
ES2500515T3
(es)
|
2007-06-19 |
2014-09-30 |
Board Of Supervisors Of Louisiana State University And Agricultural And Mechanical College |
Síntesis y utilización de análogos de fosforotioato antiinversos de la caperuza de ARN mensajero
|
US8790345B2
(en)
|
2007-08-21 |
2014-07-29 |
Zimmer, Inc. |
Titanium alloy with oxidized zirconium for a prosthetic implant
|
US8563314B2
(en)
|
2007-09-27 |
2013-10-22 |
Sangamo Biosciences, Inc. |
Methods and compositions for modulating PD1
|
SI3470077T1
(sl)
*
|
2008-02-12 |
2020-12-31 |
Amicus Therapeutics, Inc. |
Postopek za napovedovanje odgovora na zdravljenje bolezni s farmakološkim spremljevalcem
|
AU2009238629C1
(en)
|
2008-04-14 |
2015-04-30 |
Sangamo Therapeutics, Inc. |
Linear donor constructs for targeted integration
|
US8703489B2
(en)
|
2008-08-22 |
2014-04-22 |
Sangamo Biosciences, Inc. |
Methods and compositions for targeted single-stranded cleavage and targeted integration
|
EP3156494B8
(en)
|
2008-12-04 |
2018-09-19 |
Sangamo Therapeutics, Inc. |
Genome editing in rats using zinc-finger nucleases
|
EP2206723A1
(en)
|
2009-01-12 |
2010-07-14 |
Bonas, Ulla |
Modular DNA-binding domains
|
EP2459231B1
(de)
|
2009-07-31 |
2016-06-08 |
Ethris Gmbh |
Rna mit einer kombination aus unmodifizierten und modifizierten nucleotiden zur proteinexpression
|
US8956828B2
(en)
|
2009-11-10 |
2015-02-17 |
Sangamo Biosciences, Inc. |
Targeted disruption of T cell receptor genes using engineered zinc finger protein nucleases
|
EP2615106B1
(en)
|
2010-02-08 |
2018-04-25 |
Sangamo Therapeutics, Inc. |
Engineered cleavage half-domains
|
CA2788850C
(en)
|
2010-02-09 |
2019-06-25 |
Sangamo Biosciences, Inc. |
Targeted genomic modification with partially single-stranded donor molecules
|
JP5437895B2
(ja)
|
2010-04-20 |
2014-03-12 |
株式会社ジャパンディスプレイ |
表示装置及びその製造方法
|
US8771985B2
(en)
|
2010-04-26 |
2014-07-08 |
Sangamo Biosciences, Inc. |
Genome editing of a Rosa locus using zinc-finger nucleases
|
KR101974036B1
(ko)
|
2010-05-03 |
2019-04-30 |
상가모 테라퓨틱스, 인코포레이티드 |
아연 핑거 모듈을 연결하기 위한 조성물
|
CA2798988C
(en)
|
2010-05-17 |
2020-03-10 |
Sangamo Biosciences, Inc. |
Tal-effector (tale) dna-binding polypeptides and uses thereof
|
CA2805442C
(en)
|
2010-07-21 |
2020-05-12 |
Sangamo Biosciences, Inc. |
Methods and compositions for modification of an hla locus
|
WO2013044008A2
(en)
|
2011-09-21 |
2013-03-28 |
Sangamo Biosciences, Inc. |
Methods and compositions for regulation of transgene expression
|
AU2012328682B2
(en)
|
2011-10-27 |
2017-09-21 |
Sangamo Therapeutics, Inc. |
Methods and compositions for modification of the HPRT locus
|
CA2854819C
(en)
|
2011-11-16 |
2022-07-19 |
Sangamo Biosciences, Inc. |
Modified dna-binding proteins and uses thereof
|
PL2794651T3
(pl)
|
2011-12-22 |
2022-12-27 |
F.Hoffmann-La Roche Ag |
Kombinacje elementów wektora ekspresyjnego, nowe sposoby generowania komórek produkcyjnych i ich zastosowanie do rekombinowanej produkcji polipeptydów
|
US20140001721A1
(en)
|
2012-06-28 |
2014-01-02 |
John C. Benko |
Ergonomic cart
|
HUE051612T2
(hu)
|
2012-07-11 |
2021-03-01 |
Sangamo Therapeutics Inc |
Eljárások és készítmények lizoszomális tárolási betegségek kezelésére
|
US10648001B2
(en)
*
|
2012-07-11 |
2020-05-12 |
Sangamo Therapeutics, Inc. |
Method of treating mucopolysaccharidosis type I or II
|
ES2824024T3
(es)
|
2012-10-10 |
2021-05-11 |
Sangamo Therapeutics Inc |
Compuestos modificadores de células T y usos de los mismos
|
AU2013355327A1
(en)
|
2012-12-05 |
2015-06-11 |
Sangamo Therapeutics, Inc. |
Methods and compositions for regulation of metabolic disorders
|
US20140310830A1
(en)
|
2012-12-12 |
2014-10-16 |
Feng Zhang |
CRISPR-Cas Nickase Systems, Methods And Compositions For Sequence Manipulation in Eukaryotes
|
US8697359B1
(en)
|
2012-12-12 |
2014-04-15 |
The Broad Institute, Inc. |
CRISPR-Cas systems and methods for altering expression of gene products
|
WO2014182700A1
(en)
|
2013-05-10 |
2014-11-13 |
Sangamo Biosciences, Inc. |
Delivery methods and compositions for nuclease-mediated genome engineering
|
CA2910489A1
(en)
|
2013-05-15 |
2014-11-20 |
Sangamo Biosciences, Inc. |
Methods and compositions for treatment of a genetic condition
|
EP3988654A1
(en)
|
2013-08-28 |
2022-04-27 |
Sangamo Therapeutics, Inc. |
Compositions for linking dna-binding domains and cleavage domains
|
TWI793159B
(zh)
|
2013-10-23 |
2023-02-21 |
美商健臻公司 |
重組醣蛋白及其用途
|
ES2813367T3
(es)
*
|
2013-12-09 |
2021-03-23 |
Sangamo Therapeutics Inc |
Métodos y composiciones para ingeniería genómica
|
GB201322798D0
(en)
|
2013-12-20 |
2014-02-05 |
Oxford Biomedica Ltd |
Production system
|
BR112016025849A2
(pt)
|
2014-05-08 |
2017-10-17 |
Chdi Foundation Inc |
métodos e composições para o tratamento da doença de huntington
|
WO2016011448A2
(en)
|
2014-07-18 |
2016-01-21 |
Celltheon Corporation |
Methods and compositions for expression of polypeptides in a cell
|
US9816074B2
(en)
|
2014-07-25 |
2017-11-14 |
Sangamo Therapeutics, Inc. |
Methods and compositions for modulating nuclease-mediated genome engineering in hematopoietic stem cells
|
US9616090B2
(en)
|
2014-07-30 |
2017-04-11 |
Sangamo Biosciences, Inc. |
Gene correction of SCID-related genes in hematopoietic stem and progenitor cells
|
MA41346A
(fr)
|
2015-01-12 |
2017-11-21 |
Juno Therapeutics Inc |
Eléments régulateurs post-transcriptionnels d'hépatite modifiée
|
US10179918B2
(en)
|
2015-05-07 |
2019-01-15 |
Sangamo Therapeutics, Inc. |
Methods and compositions for increasing transgene activity
|
CA2990193A1
(en)
|
2015-06-23 |
2016-12-29 |
The Children's Hospital Of Philadelphia |
Modified factor ix, and compositions, methods and uses for gene transfer to cells, organs and tissues
|
CN113636947A
(zh)
|
2015-10-28 |
2021-11-12 |
爱康泰生治疗公司 |
用于递送核酸的新型脂质和脂质纳米颗粒制剂
|
CN108473976B
(zh)
|
2015-10-28 |
2022-07-19 |
桑格摩生物治疗股份有限公司 |
肝特异性构建体、因子viii表达盒及其使用方法
|
CA3011049A1
(en)
|
2016-02-02 |
2017-08-10 |
Sangamo Therapeutics, Inc. |
Compositions for linking dna-binding domains and cleavage domains
|
SG11201901364VA
(en)
|
2016-08-24 |
2019-03-28 |
Sangamo Therapeutics Inc |
Engineered target specific nucleases
|
BR112019007210A2
(pt)
|
2016-10-20 |
2019-08-13 |
Sangamo Therapeutics Inc |
métodos e composições para o tratamento da doença de fabry
|
US20180185516A1
(en)
|
2016-12-09 |
2018-07-05 |
Sangamo Therapeutics, Inc. |
Delivery of target specific nucleases
|
TW201829770A
(zh)
|
2017-01-10 |
2018-08-16 |
美商阿米庫斯醫療股份有限公司 |
用於治療fabry氏病之重組α-半乳糖苷酶A
|
JOP20190200A1
(ar)
|
2017-02-28 |
2019-08-27 |
Univ Pennsylvania |
تركيبات نافعة في معالجة ضمور العضل النخاعي
|
KR20190040920A
(ko)
|
2017-10-11 |
2019-04-19 |
(주)셀트리온 |
고발현 및 고기능성 목적 단백질의 생산을 위한 발현 카세트 및 이의 이용
|
KR20200118468A
(ko)
|
2018-02-08 |
2020-10-15 |
상가모 테라퓨틱스, 인코포레이티드 |
조작된 표적 특이적 뉴클레아제
|
EP3863663A2
(en)
|
2018-10-10 |
2021-08-18 |
Amicus Therapeutics, Inc. |
Disulfide bond stabilized polypeptide compositions and methods of use
|
EP3906043A4
(en)
|
2019-01-04 |
2022-10-26 |
Sangamo Therapeutics, Inc. |
METHODS AND COMPOSITIONS FOR TREATING FABRY'S DISEASE
|